Digital health funding in the United States surged to $7.4 billion in the first half of 2026, according to a report from Rock Health.
Investment climbs despite a tighter pool of recipients
The venture‑capital market funneled $7.4 billion across 244 deals, surpassing last year’s $6.4 billion while keeping the number of financing rounds roughly the same. Median deal size rose to $14 million, up from $12 million in 2025.
Larger rounds—defined as $100 million or more—accounted for 45 percent of all capital deployed.
While the overall amount of money grew, the share of funding concentrated in a smaller group of firms. Nineteen companies secured 20 mega‑deals in the first half of the year, a decline from the 27 such deals recorded in 2025.
In the first quarter, startups raised $4.2 billion; the second quarter added $3.2 billion. Both figures sit just under last year’s second‑quarter total of $3.4 billion.
Sector focus shifts toward mental health and weight management
Mental‑health platforms retained the top spot for the seventh consecutive year, drawing the most investment among clinical indications. Weight‑management firms followed closely, buoyed by strong demand for GLP‑1–based treatments.
Artificial intelligence, once a differentiator, has become commonplace across digital health offerings. Rock Health notes that AI now influences investor preferences more than it distinguishes product strategy. Its authors wrote, “AI has made more tailored implementations possible, but has also flooded buyers with new options, raising expectations for measurable ROI and leaving little appetite for failed deployments.”
Related: Intuitive links Q2 slowdown to ACA subsidy end
Investors appear to favor founders with prior healthcare experience, believing such expertise helps address buyer concerns and accelerates scaling. Companies are also pursuing strategic partnerships to bolster credibility and to support the rollout of AI‑driven tools.
Acquisitions continued at a brisk pace, with 115 deals recorded in the first half of the year. That number exceeds the total of 199 deals seen in the previous full year and outpaces the 121 acquisitions logged in 2024.
Growth remains uneven.
Public market exits remain limited. Seven firms went public in 2025, including Hinge Health and Omada Health, but none have listed shares in 2026 so far. Wearable‑maker Oura is reportedly approaching a potential IPO.
For patients, the concentration of capital in a few large players could mean faster access to sophisticated AI‑enabled services, yet it may also narrow the range of options available from smaller innovators. The trade‑off between scale and diversity will likely shape how quickly new tools reach everyday care settings.
Overall, the data suggest that the digital health sector is sustaining its recent upswing, driven by sizable funding rounds and a continued appetite for AI‑infused solutions.